Glutaminyl Cyclase, Diseases, and Development of Glutaminyl
Por um escritor misterioso
Descrição
Frontiers Development and evolution of human glutaminyl cyclase inhibitors (QCIs): an alternative promising approach for disease-modifying treatment of Alzheimer's disease
Glutaminyl cyclases unfold glutamyl cyclase activity under mild acid conditions - ScienceDirect
IsoQC (QPCTL) knock-out mice suggest differential substrate conversion by glutaminyl cyclase isoenzymes
Discovery of highly potent human glutaminyl cyclase (QC) inhibitors as anti-Alzheimer's agents by the combination of pharmacophore-based and structure-based design - ScienceDirect
Upregulation of Glutaminyl Cyclase Contributes to ERS-Induced Apoptosis in PC12 Cells
Increased glutaminyl cyclase activity in brains of Alzheimer's disease individuals - Gunn - 2021 - Journal of Neurochemistry - Wiley Online Library
Inhibitors for Human Glutaminyl Cyclase by Structure Based Design and Bioisosteric Replacement
2.3.2.5: glutaminyl-peptide cyclotransferase - BRENDA Enzyme Database
Glutaminyl cyclase - Proteopedia, life in 3D
A glutaminyl cyclase-catalyzed α-synuclein modification identified in human synucleinopathies
Human glutaminyl cyclase: Structure, function, inhibitors and involvement in Alzheimer's disease - ScienceDirect
Marine Drugs, Free Full-Text
An overview of glutaminyl cyclase inhibitors for Alzheimer's disease
de
por adulto (o preço varia de acordo com o tamanho do grupo)
